Why the study?
Does the formation of anti-HLA antibodies reduce survival in heart allograft recipients?
Population
107 heart allograft recipients
Comparison
Formation of anti-HLA antibodies vs Recipients who developed no anti-HLA antibodies
Design
Cohort
Follow-up
4 years
Authors
Loading...
Anti-HLA antibody formation was associated with lower survival after heart transplant; hypothesis-generating and requires prospective validation before guiding care.
Does the formation of anti-HLA antibodies reduce survival in heart allograft recipients?
The formation of anti-HLA antibodies in heart transplant recipients is associated with significantly lower 4-year survival, suggesting a key role in chronic rejection.
Suciu‐Foca et al. (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: